Silica-Chitosan Xerogel Composite Nanospheres for Controlled Release of Lisinopril | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.


Silica-Chitosan Xerogel Composite Nanospheres for Controlled Release of Lisinopril

Author(s): Somayeh Sadighian, Seyyed Aliasghar Arjmandi, Sahar Najaflou

Single- and double-layered nanocomposites prepared by encapsulation of lisinopril-loaded silica xerogels with the biodegradable polymer chitosan. The in vitro drug release profile from both the nanocomposites and bare nanospheres investigated. The single-layered nanocomposites (silica xerogel) showed an initial burst, followed by two sustained release stages lasting for 13 days. In comparison with the silica xerogel nanocomposites, the silica xerogel/ Chitosan nanocomposites released a reduced initial burst together with three sustained release stages. The silica xerogel/chitosan nanocomposites can provide additional advantages in the localized drug delivery applications, as compared to the silica xerogel.

Full-Text PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry